Below are the most recent publications written about "Uterine Cervical Dysplasia" by people in Profiles.
-
Anderson JR, Yogeshkumar S, Lu E, Yenokyan G, Thaler K, Mensa M, Chikaraddi S, Lokare L, Gudadinni MR, Antartani R, Donimath K, Patil B, Bidri S, Goudar SS, Derman R, Dalal A. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India. BJOG. 2023 Nov; 130(Suppl 3):158-167.
-
Kohler RE, Hemler J, Wagner RB, Sullivan B, Macenat M, Tagai EK, Miller SM, Wen KY, Ayers C, Einstein MH, Hudson SV. Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown". Patient Educ Couns. 2023 09; 114:107810.
-
Yogeshkumar S, Anderson J, Lu E, Kenyi E, Mensa M, Thaler K, Antartani R, Donimath K, Patil B, Chikaraddi S, Bidri S, Biradar A, Gudadinni MR, Lokare L, Yenokyan G, Bellad MB, Goudar SS, Derman R, Revankar A, Patil H, Wani R, Kangle R, Chavan RY, Nagmoti MB, Kabadi YM, Reddy P, Vernekar S, Hipparagi S, Patil V, Dalal A. Safety and efficacy of the new CryoPop? cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls. Trials. 2021 Dec 13; 22(1):915.
-
Young S, Vaughan L, Yanson K, Eckert K, Li A, Harris J, Ermel A, Williams JA, Al-Ghoul M, Cammarata CL, Taylor SN, Luff R, Cooper CK, Van Der Pol B. Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus. J Clin Microbiol. 2020 12 17; 59(1).
-
Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 09; 70(5):321-346.
-
Perrone AM, Bovicelli A, D'Andrilli G, Borghese G, Giordano A, De Iaco P. Cervical cancer in pregnancy: Analysis of the literature and innovative approaches. J Cell Physiol. 2019 09; 234(9):14975-14990.
-
HooKim K, Lieberman RW, Smola BM, Knoepp SM. "Equivocal" high-risk HPV DNA tests performed on ThinPrep specimens after ASC-US diagnoses are associated with an increased incidence of CIN3: a cytologic/histologic review of 315 cases. J Low Genit Tract Dis. 2014 Oct; 18(4):291-7.
-
Song D, Kim E, Huang X, Patruno J, Munoz-Avila H, Heflin J, Long LR, Antani S. Multimodal entity coreference for cervical dysplasia diagnosis. IEEE Trans Med Imaging. 2015 Jan; 34(1):229-45.
-
Madeddu G, Mameli G, Capobianco G, Babudieri S, Maida I, Bagella P, Rocca G, Cherchi PL, Sechi LA, Zanetti S, Nunnari G, Dessole S, Mura MS. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. Eur Rev Med Pharmacol Sci. 2014; 18(8):1277-85.
-
de la Cruz MS, Young AP, Ruffin MT. Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians. J Am Board Fam Med. 2013 Nov-Dec; 26(6):720-7.